Deals, Insight journal - Dealtalk, M&A

Will Sanofi, Genzyme chiefs talk deal at JPMorgan?

Posted on 07 January 2011

Tags: , ,

Could it be time to talk in the long-running saga of Sanofi-Aventis' $18.5 billion bid for Genzyme?

CEO Chris Viehbacher and Henri Termeer will have the chance when they give back-to-back presentation's at next week's JPMorgan Healthcare Conference..

Read the latest report on the Sanofi bid for Genzyme at Reuters

 

Print Friendly, PDF & Email

Leave a Reply